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Abstract
Background: We have developed a rat cell model for studying collagen type I production in
coronary artery adventitial fibroblasts. Increased deposition of adventitial collagen type I leads to
stiffening of the blood vessel, increased blood pressure, arteriosclerosis and coronary heart
disease. Although the source and mechanism of collagen deposition is yet unknown, the adventitia
appears to play a significant role. To demonstrate the application of our cell model, cultured
adventitial fibroblasts were treated with sex hormones and the effect on collagen production
measured.
Methods: Hearts (10–12 weeks) were harvested and the left anterior descending coronary artery
(LAD) was isolated and removed. Tissue explants were cultured and cells (passages 2–4) were
confirmed as fibroblasts using immunohistochemistry. Optimal conditions were determined for cell
tissue harvest, timing, proliferation and culture conditions. Fibroblasts were exposed to 10-7 M
testosterone or 10-7 M estrogen for 24 hours and either immunostained for collagen type I or
subjected to ELISA.
Results:  Results showed increased collagen staining in fibroblasts treated with testosterone
compared to control and decreased staining with estrogen. ELISA results showed that testosterone
increased collagen I by 20% whereas estrogen decreased collagen I by 15%.
Conclusion: Data demonstrates the usefulness of our cell model in studying the specific role of
the adventitia apart from other blood vessel tissue in rat coronary arteries. Results suggest
opposite effects of testosterone and estrogen on collagen synthesis in the rat coronary artery
adventitial fibroblasts.
Background
Cardiovascular disease is the number one cause of death
in the United States. Diseases such as hypertension and
coronary artery disease develop through multiple mecha-
nisms; of significance are the structural changes that take
place within blood vessels. In vivo data has shown that
coronary artery fibrosis can result as a consequence of
high blood pressure (BP). In addition to elevated BP, tes-
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tosterone has been shown to increase the amount of col-
lagen measured around coronary blood vessels
contributing to fibrosis. For example, Seachrist found that
testosterone increased coronary adventitial collagen in
male hypertensive rats independent of the renin-angi-
otensin system [1]. Studies have provided further evi-
dence for the role of testosterone in coronary artery
fibrosis in male borderline hypertensive rats. Sympathec-
tomy reduced systolic BP, but more interestingly reduced
plasma testosterone levels correlated with decreased coro-
nary artery collagen deposition [2].
Historically, the adventitia has not been considered to be
involved in the disease process associated with the blood
vessel wall. In blood vessels, pathological changes have
typically been attributed to detrimental alterations in
endothelial function or the vascular smooth muscle
(VSM) layer, whereas the role of the adventitia has been
relegated to that of structural support. However, recent
clinical and experimental research in coronary artery dis-
ease demonstrates that the adventitia does play an active
role in the dynamic vascular remodeling in response to
injury [3,4]. The adventitia participates in the response to
endoluminal vascular injury in several animal models
[5,6]. Female Sprague-Dawley rats subjected to carotid
artery balloon injury showed migration of adventitial
fibroblasts to the neointima [5]; and in the calf model,
hypoxia induced a dramatic expansion of the pulmonary
artery vaso vasorum via activation of fibroblasts [7].
Remodeling of the adventitial layer in canine coronary
artery involves activation and proliferation of adventitial
fibroblasts accompanied by expression of growth factors
[7].
One structural change as a result of hypertension in both
arteries and the heart is an increase in the amount of col-
lagen. Collagen is synthesized by VSM cells, fibroblasts
and myofibroblasts. Fibroblasts are usually credited for
the majority of collagen in vascular tissue [8] and mainte-
nance of the extracellular matrix, however, myofibroblasts
are known to produce substantial amounts of collagen as
well [9]. Fibroblasts can differentiate into myofibroblasts
under a variety of stimuli and pathological conditions and
alter collagen production [10]. For example, the cytoki-
neTGF-β can induce the differentiation of fibroblasts to
myofibroblasts and increase collagen production [11].
Collagen normally functions to impart structural integrity
to the blood vessel wall, but in disproportionate amounts,
it increases stiffness and blood vessel resistance, ulti-
mately resulting in increased BP in hypertension. Besides
collagen production, fibroblasts can function in a variety
of ways. They are capable of migration to the injury site,
pronounced proliferation, synthesis of other extracellular
matrix proteins and vascular remodeling in response to
injury or mechanical stress [12-14]. Besides structural
functions, fibroblasts have an additional role through the
release of cytokines or other regulatory molecules [15,16].
One limitation of in vivo studies is the inability to deter-
mine the role of the fibroblasts independent of the
endothelium and VSM layers. Cell culture circumvents
this problem and can be used to determine the role of
fibroblasts in the absence of other cell types. Most cell cul-
ture models study collagen and fibrosis of the myocar-
dium and aorta; however, the influence of coronary artery
fibroblasts has not been adequately addressed, particu-
larly fibroblasts from the spontaneously hypertensive rat
(SHR), a well studied model of essential hypertension.
Thus the goal of this study was to culture adventitial
fibroblasts from SHR coronary arteries to provide a tool
for studying the effect of sex hormones on collagen as it
relates to hypertension and vascular remodeling.
Methods
Animals
SHR were housed in polyethylene cages (45 × 25 × 20 cm)
with stainless steel tops using heat treated wood chip bed-
ding (P.J. Murphy Forest Products, Montville, NJ, USA).
Rat chow (Teklad Rodent diet, Madison, WI, USA) and
water were provided ad libitum. Animals were kept in con-
stant conditions (25–27°C, 40–50% humidity, and a 12
hour light (0600–1800 h)/dark cycle (1800–0600 h). All
procedures were in accordance with the National Insti-
tutes of Health guidelines on humane treatment of ani-
mals and approved by the University of Akron
Institutional Animal Care and Use Committee.
Tissue Harvest
Adult SHR rats (250 g) (10–12 weeks) were anesthetized
with 0.5 cc sodium pentothal (50 mg/ml, i.p.; Fort Dodge
Animal Health, Fort Dodge, IA, USA), prepared for sur-
gery, and the heart and thoracic aorta were removed and
placed in cold, sterile buffer, either Kreb's Henseleit
(Kreb's), Hepes buffered saline (HBS) or phosphate buff-
ered saline (PBS). Hearts were pinned on sterile paraffin
in petri dishes and sterile technique observed. The left
anterior descending coronary artery (LAD) was isolated
and removed from the heart (Figures 1A, 1B), maintained
in buffer and dissected free of any extra tissue (Olympus
SZX-12; Center Valley, PA, USA) (Figure 1C). The average
size of the LAD was 6–10 mm in length and 0.5 mm in
diameter (Figure 1D, 1E). Each LAD was sectioned into 3
mm pieces and placed in one standard 35 mm tissue cul-
ture dish. Due to anatomical differences between animals
and the amount of branching of the left coronary artery,
additional segments of blood vessels were collected from
these coronary branches when possible.BMC Cardiovascular Disorders 2007, 7:13 http://www.biomedcentral.com/1471-2261/7/13
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For blood vessel dissection, early experiments attempted
to process the LAD much like other blood vessels (aorta)
[17,18], using collagenase and elastase digestion to facili-
tate the separation of the blood vessel layers. However the
rat LAD is significantly smaller and has a reduced medial
layer compared to the aorta, and when we attempted
enzymatic separation of the layers we found it extremely
rigorous and the tissue too fragile to yield viable cells.
Consequently, enzyme digestion was not used to harvest
fibroblasts from the rat coronary artery and intact tissue
explants were plated. Explants were allowed to adhere to
the culture dish in the absence of culture medium. After
fibroblasts began to migrate, tissue explants were removed
to minimize the introduction of contaminating cell types
from the media or endothelial layers (Figure 1F). The time
elapsed between removal of the heart and plating of the
LAD explant was approximately 20–30 minutes.
In addition to LAD fibroblasts, fibroblasts were also cul-
tured from the thoracic aorta and ventricle for compara-
tive purposes. The thoracic aorta was cleaned of any
additional tissue and flushed with buffer to remove any
remaining blood. The vessel was then cut longitudinally,
the endothelium gently scraped to remove any endothe-
lial cells, cut into 4 × 6 mm sections and plated adventitial
side down. Fibroblasts migrated from aortic tissue
explants within 5–7 days at which time the explant was
removed.
Ventricular fibroblasts were harvested from the heart
using a modification of published methods [19]. Briefly,
after LAD removal, the heart was placed in ADS buffer
(116 mM NaCl, 20 mM Hepes, 1.0 mM NaH2PO4, 5 mM
KCl, 0.8 mM Mg2SO4, 5.5 mM glucose, pH 7.4) and the
large vessels and atria were removed. The ventricles were
then minced, placed in a Wheaton CEL-STIR flask and
digested with trypsin (0.6 mg/ml) and collagenase (100
U/ml) (both from Worthington Biochemicals, Newark,
NJ, USA) in ADS buffer. Fetal bovine serum was added to
stop digestion, the cell suspension centrifuged and the
remaining pellet resuspended in 5 ml cell culture medium
and plated to a 60 mm plate. Cardiac fibroblasts were
allowed to attach to culture dishes for 45 minutes before
medium was removed and transferred to a second 60 mm
tissue culture plate. Fresh medium was added to the orig-
inal plate and the same procedure was followed for the
second 60 mm plate. Non-adherent cells were washed
away 24 hours later.
Cell Culture
Combinations of tissue culture medium were tested:
Ham's F12K and Dulbecco's Modified Eagles Medium
(DMEM; Invitrogen, Carlsbad, CA, USA) separately and a
50/50 combination of the two. All medium was supple-
mented with antibiotic/antimycotic (2 U/ml penicillin, 2
μg/ml streptomycin and 5 ng/ml amphotericin B; Sigma,
St. Louis, MO, USA). Fetal bovine serum (FBS) concentra-
tion was incrementally decreased (20 -15 -10 percent)
with each passage. Cell preparations were kept at 37°C in
a humidified atmosphere of 95% air/5% CO2. Cells from
early passages (P2 to P4) were cultured on microscope
slides at a subconfluent density of 5 × 104/well (11.5 mm
diameter; Erie Scientific, Portsmouth, NH, USA), incu-
bated overnight to allow for attachment, and subjected to
Removal of left anterior descending coronary artery (LAD)  from SHR male rat Figure 1
Removal of left anterior descending coronary artery (LAD) 
from SHR male rat. A) intact LAD, B) heart with LAD 
removed, C) isolated LAD, D) LAD length, E) LAD diameter, 
and F) fibroblasts migrating from LAD explant.BMC Cardiovascular Disorders 2007, 7:13 http://www.biomedcentral.com/1471-2261/7/13
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immunohistochemistry (IHC) for cell verification or sub-
jected to drug treatments.
Cell Verification
Verification and viability of the fibroblastic cell line was
determined by IHC staining. Cells were incubated 1 hr at
37°C with one of the following antibodies: mouse anti-
vimentin directly conjugated with Cy 3 (1:400), mouse
anti-α smooth muscle actin (α-SMA) antibody directly
conjugated with FITC (1:1000), or primary mouse anti-
desmin antibody (1: 200) with secondary horse anti-
mouse IgG FITC labeled antibody (1:100)(all were from
Sigma, St. Louis, MO, USA). VSM cells harvested from
male SHR aorta were used as positive controls. Stained
cells were viewed with an Olympus B-Max 60 microscope
equipped with epiflourescence (Olympus, Center Valley,
PA, USA) and pictures acquired digitally with a Retiga
cooled CCD camera (Q Imaging, Burnaby, BC, Canada).
Drug Treatment
To demonstrate that this model for culturing LAD fibrob-
lasts has a direct application in vascular studies, fibrob-
lasts were treated with sex hormones to induce changes in
collagen type I production. For IHC, fibroblasts were
plated on slides as described above and incubated in
serum free, phenol red free media for 24 h prior to treat-
ment. Cells were treated for an additional 24 h with either
10-7M testosterone or 10-7M estrogen (both from Sigma,
St. Louis, MO, USA) and subsequently immunostained
for collagen type I with rabbit anti-rat collagen type I pol-
yclonal antibody (1:40; Chemicon, Temecula, CA, USA)
and fluorescein labeled secondary antibody (1:100; Vec-
tor Laboratories, Burlingame, CA, USA). For quantitative
collagen measurements, fibroblasts were plated at a den-
sity of 6 × 103 in a 96 well tissue culture treated microtitre
plates (Becton -Dickinson). After 24 h incubation, basal
culture medium was replaced with serum free, phenol red
free medium for an additional 24 hours. Fresh serum free
phenol red free medium with either 10-7M testosterone
10-7M estrogen was then added for 24 h of drug treatment.
Quantification of Collagen Type I
ELISA techniques were used to measure collagen type I.
Briefly, cells were fixed in 3.7 % formaldehyde for 10 min-
utes at room temperature (R.T.), washed and permeabi-
lized with Triton X- 100 (0.3% in PBS) for 10 minutes at
R.T. and washed again. All washes were conducted with a
0.1% Tween 20 in PBS. A blocking agent (2.5% BSA in
PBS/Tween 20) was added to each well and incubated for
1 hour at R.T. or overnight at 4°C and then washed before
adding the primary antibody. Cells were then incubated
for 1 hour at 37°C with 50 μl/well of rabbit anti-rat colla-
gen type I polyclonal antibody (1:500; Chemicon, Temec-
ula, CA, USA), washed and then incubated 1 hour at 37°C
with a goat anti- rabbit IgG secondary antibody conju-
gated with horseradish peroxidase. Plates were washed
and 200 μl of substrate solution made with Sigma FAST
OPD (o-phenylenediamine dihydrochloride) tablets dis-
solved in 20 ml of distilled water. Final concentrations are
0.4 mg/ml OPD, 0.4 mg/ml urea hydrogen peroxide, and
0.05 M phosphate-citrate, pH 5.0. The enzyme reaction
was stopped after 30 min incubation at room temperature
(in the dark) by the addition of 50 μl of 2 M H2SO4 to each
well. Plates were then read at 450 nm (SoftMax Pro soft-
ware) on a SpectraMax Plus multiwell plate reader
(Molecular Devices).
Results
Tissue Harvest
During dissection we found that minimal manipulation
of the LAD ensured that cells were more likely to migrate
from the tissue explant. Initially, different buffers (Kreb's,
HBS, or PBS) were tested to determine if the different buff-
ering capacity (bicarbonate vs. Hepes) had any effect on
tissue viability. Explants processed in PBS (~40–50% suc-
cess rate) did not produce as many cells as those main-
tained in Kreb's or HBS (~80–90% success rate) (Table 1).
However, there were no observable differences between
Kreb's and HBS buffers used during dissection which
changed any experimental results. If explants did not
adhere to the culture dish, then no cells were obtained
from that explant.
Timing and Age of Animal
We established the optimal time from the removal of the
heart to the time when the LAD was plated for cell culture.
In preliminary experiments the time elapsed was as great
as 2 hours. The longer the time lapse between the removal
of the heart and the plating of the vessel, the less success-
ful the culture. The minimum amount of time from vessel
removal to culture medium was approximately 25 min-
utes and proved to yield the greatest number of cells, indi-
cating the importance of speed at this stage (Table 1).
In younger animals (10–12 weeks of age) 80–90% of the
explants survived. Cultures from older animals (18–30
weeks of age) did not thrive and typically only 25–30% of
the explants produced cells and in the oldest animals (30+
weeks of age) no cells survived (Table 1).
Proliferation
The proliferation rate was different when comparing
fibroblasts from LAD, aorta and ventricle. In early experi-
ments explants from LAD and aortic fibroblast were both
started (P0) in 35 mm dishes for comparison purposes.
The average number of fibroblasts from passage one (P1),
LAD had 4 × 105 cells/11.78 cm2 in one 35 mm culture
dish in contrast to the aorta which had a total of two 35
mm dishes each with an average of 2 × 106 cells/11.78
cm2. Those same cultures were maintained to passage 3BMC Cardiovascular Disorders 2007, 7:13 http://www.biomedcentral.com/1471-2261/7/13
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(P3) and the average cell number was 6 × 105/11.78 cm2
still in one 35 mm dish, whereas the number of P3 aortic
fibroblasts had increased to two 60 mm dishes each with
3 × 106/21.29 cm2 cells.
To demonstrate the difference in the total number of
fibroblasts and rates of proliferation, cells were counted in
later experiments where we attempted to harvest the max-
imal amount of fibroblasts from each tissue. LAD explants
yielded the same number of cells as mentioned above but
since the amount of aortic tissue available was greater so
is the potential for more fibroblasts. In fact, if 10 aortic
explants were started (P0) in a 100 mm dish there was
1.4× the number of P1 fibroblasts compared to LAD and
3× the number of P3 fibroblasts (Table 2). Comparing the
number of fibroblasts from both ventricles to the LAD,
there were 9× more cells at P1 and 364× more cells at P3.
The change in the number of cells from P1 to P3 demon-
strates how different the rate of proliferation was for each
tissue. The number of cells increased 1.5× in LAD com-
pared to 3.2× in aorta and 60.7× in ventricles (Table 2).
Once the initial explant was established, it took 5–7 days
for fibroblasts to migrate out from the explant and to
increase in numbers large enough to sustain themselves
once the explant was removed (7–10 days) (P0). At that
time cells were often clumped in dense patches, so they
were trypsinized to evenly disperse them into another 35
mm dish (P1). After an additional 4–7 days, if cells were
confluent they were passed in a 1:2 dilution (P2) to
another 35 mm dish. However, if cells had not reached
confluency (~85%) at this time, it was important to pass
them without allowing additional time in the same cul-
ture dish. The vigor needed to remove P1 or P2 cells that
had been plated more than 7 days resulted in increased
cell death. Because of this, P1 cells at less than 85% conflu-
ency were passed at the 4–7 day point to 2–3 wells in a 12
well plate instead of a 35 mm dish. This provided a
smaller growth area of 3.8 cm2 compared to 11.78 cm2
and ensured an optimum cell density. After another 4–6
days cells were passed (P3) if they were actively dividing.
More consistent results were found when using early pas-
sage cells (P2 to P3) for drug treatments and the optimal
age of the fibroblasts appears to be from 15–24 days after
removal from the animal. Proliferation decreased dramat-
ically at or beyond P3 and cell morphology was altered.
For instance, the cells were more firmly attached to the
substrate, had increased contrast compared to younger
cells and were flatter with cytoplasmic extensions. The
ratio of cytoplasmic area compared to nuclear area was
much greater in older cells.
Culture conditions
Composition of the culture medium was another impor-
tant factor in cultivating fibroblasts. Coronary artery
fibroblasts grew best in the 50/50 mixture of DMEM and
Ham's F12K. All culture medium was supplemented with
FBS and antibiotic/antimycotic solutions. The explant cul-
Table 1: Explant Success by Experimental Variables
Type of Buffer
PBS HBS Kreb's
Percent of successful explants 40–50% 80–90% 80–90%
Time from Tissue Harvest to Culture
< 1 hr 1–2 hrs > 2 hrs
Percent of successful explants 80–90% 50–60% 0–5%
Age of Animal
10–12 wks 18 wks > 30 wks
Percent of successful explants 80–90% 25–30% 0%
Table 2: Cell Density and Fold Change by Tissue and Passage Number
Cells/cm2 Fold Change
Passage 1 Passage 3 P1-P3 P1 (compared to LAD) P3 (compared to LAD)
LAD 3.4 × 104 5.0 × 104 1.5 × --- ---
Aorta 4.7 × 104 15.2 × 104 3.2 × 1.4 × 3.0 ×
Ventricle 3.0 × 105 18.2 × 106 60.7 × 9.0 × 364 ×BMC Cardiovascular Disorders 2007, 7:13 http://www.biomedcentral.com/1471-2261/7/13
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tures supplemented with 20% FBS were more successfully
established than those initiated with only 10% FBS, there-
fore 20% FBS was used in the medium for explants and P0
cells. As the cells were subcultured, the amount of FBS was
reduced incrementally to 15% and 10%, respectively,
prior to drug treatments. The reason for this procedure
was that the immediate change from 20% FBS to serum
free media was too severe and resulted in increased cell
death.
Experiments were conducted when P1 fibroblasts were
passed into either one 60 mm dish, multiple 12 wells or
35 mm dishes until we realized that cells in the larger dish
stopped dividing. LAD explants initially started in 35 or
60 mm dishes and were only successful in the 35 mm
plates.
Cell Characterization
Since explants were from intact blood vessels, all tissue
layers were present. Consequently, cell types cultured
were verified using IHC to ensure the cells tested were
indeed fibroblasts. Fibroblasts stained positive for vimen-
tin, but not for α-SMA or desmin. VSM cells from male
SHR aorta were used as positive controls and stained pos-
itive for all three cytoskeletal proteins: α-SMA, desmin
and vimentin (Figure 2). The absence of endothelial cells
was confirmed morphologically. It should be emphasized
that the cells used in this study were from early passages.
Cells that were maintained longer at P3 and into P4 or
plated at lower densities showed positive staining for α-
SMA indicting the presences of myofibroblasts (data not
shown).
Qualitative Measure of Collagen Type I
LAD fibroblasts treated with 10-7M testosterone for 24 h
showed an increase in the intensity and amount of colla-
gen type I stained as well as more pronounced secretory
vesicles in stimulated cells (Figure 3A). Cells treated with
10-7M estrogen for the same time period appeared similar
to control (Figure 3B).
Quantitative Measure of Collagen Type I
Cells treated with testosterone (N = 22 animals, 84 wells)
had 2.912 ± 0.247 μg/well of collagen type I compared to
control values 2.475 ± 0.211 μg/well (N = 26 animals, 132
wells) (Figure 4). This represents a 20% increase in the
amount of collagen type I deposited by the fibroblasts in
a 24 hr period (p = 0.04, 1- tailed t test).
However, cells treated with estrogen (N = 18 animals, 81
wells) showed the opposite effect compared to testoster-
one by decreasing the amount of collagen deposited by
15%. Estrogen treated cells produced 2.103 ± 0.262 μg/
well compared to control of 2.475 ± 0.211 μg/well (p =
0.058, 1 tailed t test) (Figure 4).
Discussion
The initial questions of this study asked whether it was
feasible to culture rat coronary artery adventitial fibrob-
lasts for experimental use, and can we demonstrate the
utility of this technique for measuring changes in collagen
as related to vascular remodeling and hypertension.
The most important outcome of this study is that we
established and optimized a new culture system for LAD
fibroblasts that provides a practical means for studying
cells involved in blood vessel pathology. Our data illus-
trates the response of adventitial fibroblasts to sex hor-
mones in the absence of other vascular cell types.
Collagen type I production was 20% higher in testoster-
one treated cells compared to control fibroblasts. This sig-
nificant increase in collagen in vitro mirrors the results we
Cell Characterization Figure 2
Cell Characterization. Cultured rat coronary artery adventi-
tia fibroblasts (LAD) and aortic vascular smooth cells (VSM) 
(positive control) stained for desmin, α-smooth muscle actin 
(α-SMA) and vimentin. LAD stained negative for desmin and 
αSMA and positive for vimentin, a fibroblast marker. VSM 
stained positive for all 3 proteins. Desmin and α-SMA are 
specific VSM markers.BMC Cardiovascular Disorders 2007, 7:13 http://www.biomedcentral.com/1471-2261/7/13
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found through in vivo experiments conducted in our lab.
Previously we have shown that testosterone has a role in
the development of hypertension as well as the resulting
pathology that can arise in coronary blood vessels. For
instance, castration of hypertensive, borderline hyperten-
sive and normotensive rat strains significantly reduced
blood pressure (20–30 mmHg) and testosterone replace-
ment in castrated males restored BP in all strains [20]. We
have also looked at the effect of testosterone on coronary
collagen deposition. Research has shown the effect of the
renin-angiotensin system (RAS) is to increase collagen
production in cardiac fibroblasts and when subjected to
an angiotensin-converting enzyme (ACE) inhibitor colla-
gen production is decreased [21,22]. We have had similar
results using an ACE inhibitor which reduced coronary
artery collagen [1]. In the same study, we found a signifi-
cant positive correlation between collagen and plasma
levels of testosterone. This finding indicates a separate and
independent effect of testosterone over the RAS in colla-
gen production.
In addition we have researched the role of the sympathetic
nervous system (SNS) in hypertension and associated
fibrosis. We found that sympathectomized rats show a
decrease in plasma testosterone and the absence of the
increase in collagen deposition typically seen around the
coronary arteries [2]. Besides the histological effect, we
also have demonstrated a link between norepinephrine
and the pathology associated with high BP and the SNS.
We used testosterone implants in both castrated normo-
tensive and castrated hypertensive rats to show that there
is a direct relationship between the levels of norepine-
phrine and testosterone [23]. To further substantiate the
role of testosterone and BP, our studies of the androgen
receptor have shown that rats with deficient androgen
receptors do not exhibit the same BP changes as those ani-
mals with functional receptors [24]. The data when taken
together demonstrate that testosterone has a role in the
coronary pathology seen with hypertension.
Another interesting finding in this study was that LAD
fibroblasts are affected in opposite ways by testosterone
and estrogen. A 15% decrease in collagen was measured in
fibroblasts treated with estrogen (Figure 4). This finding is
consistent with the reported vasoprotective effects of
estrogen [25,26] indicating that 17β-estradiol and proges-
terone may protect postmenopausal women against cardi-
ovascular disease [27]. In cardiac fibroblasts, drugs that
blocked the metabolism of estrogen intermediates
blocked the inhibitory effects of hydroxyestradiol on car-
diac fibroblast proliferation and collagen synthesis
[28,29]. A possible explanation for the different effects of
testosterone and estrogen may be that they are acting in a
different way on the synthesis and degradation of collagen
I. If the ratio between the two were altered the relative
amount of collagen I would change.
Besides illustrating the usefulness of this culture system,
another important outcome was determining the ideal
conditions to culture and maintain LAD fibroblasts while
Cultured fibroblasts immunostained for collagen type I after  24 h exposure to 10-7M testosterone or 10-7M estrogen Figure 3
Cultured fibroblasts immunostained for collagen type I after 
24 h exposure to 10-7M testosterone or 10-7M estrogen. A) 
Testosterone increased the amount of collagen present com-
pared to control (C) as indicated by the increased number of 
secretory vesicles and the intensity of staining. B) Estrogen 
did not have any significant effect on collagen production.BMC Cardiovascular Disorders 2007, 7:13 http://www.biomedcentral.com/1471-2261/7/13
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maximizing cell yield. We found that the conditions and
timing of tissue harvest, the composition of culture
medium, culture dish size and the age of the donor ani-
mal were all key variables.
The conditions of the tissue harvest and degree of vessel
manipulation proved to be critical. Three different buffers,
PBS, HBS and Kreb's were all used to maintain the tissue
while harvesting the coronary artery. Tissues initially
maintained in PBS ultimately had fewer cells compared to
those kept in the other buffers. The decreased number of
cells from explants processed in PBS could be due to the
differing composition of the buffers or that the PBS was
used initially when the technique was being developed
and other conditions had not been optimized. The fact
that the minimal amount of time from vessel removal to
culture media provided the greater number of cells is of
no surprise. Less time in buffer and a nutrient deficient
environment should minimize tissue damage and cell
death.
Another important factor was age of the animal. Develop-
mentally, many tissues consist of terminally differentiated
cells that become quiescent after a fixed number of cell
divisions. In addition to their cell division potential,
many cells become metabolically inactive after a specific
time, explaining why explants from younger animals (10–
12 weeks) yielded more cells. Animals less than 10 weeks
would most likely be viable in terms of age; however, the
younger animal provides less tissue which becomes a lim-
iting factor in the total number of cells yielded.
Not only is the total number of cells generated from LAD
explants a limiting factor due to the amount of tissue
available from one animal, but the rate at which the cells
proliferate is a constraint as well. In comparison to aortic
and ventricular fibroblasts, the growth rate of LAD fibrob-
lasts appears to be the slowest, taking longer to reach con-
fluency and have the fewest total number of cells. The
overall number of cells was dramatically different and
most likely due to the relative amount of tissue available
and the different growth rates associated with fibroblasts
of different origins. This finding is not surprising consid-
ering that studies have shown that fibroblasts exist in het-
erogeneous populations in which they have very specific
phenotypes and functions based on the tissue of origin
[30] and rat strain [31]. The decrease in cell division is
consistent with the changes seen in aging fibroblasts from
other sources such as human gingiva or foreskin [32,33],
reflecting that most cells have a finite period of viability
and are not immortal [34].
The morphological changes seen in later passage cells
could be explained by the decrease in cell division and
overall numbers of cells allowing the cells that were
present to spread out more creating a greater cytoplasmic
area to nuclear area ratio. The difficulty in removing these
cells for subculture was most likely due to the increased
deposition of extracellular matrix while in the culture dish
for a longer period of time.
Cell density and culture dish size were important as well.
Fibroblasts have been shown to be sensitive to cell density
in culture [35]. In rabbit corneal fibroblasts, Masur
showed that cell density was a critical factor in both fibro-
blast proliferation, as well as transformation of fibroblasts
to myofibroblasts [35]. In cultures where cells were
seeded at a less than optimal density, fibroblasts began to
differentiate into myofibroblasts and the rate of cell divi-
sion decreased. Our findings are consistent with this in
that the size of the culture dishes used when passing these
fibroblasts directly impacted cell density since there is ini-
tially a limited number of cells. In other studies we have
found the presence of myofibroblasts in LAD fibroblast
cultures that were plated at lower densities as well as in
older cultures (late passage 3 and 4) (data not shown).
Older cells or those plated at less than optimal density
stained positively for α-SMA indicating that they had dif-
ferentiated to myofibroblasts. However, the cells in this
study were plated in 35 mm culture dishes and used while
younger in early passages. Fibroblast cell type was con-
firmed by positive staining for desmin and negative stain-
Collagen Type I (μg) measured by ELISA in LAD fibroblasts  treated with 10-7M testosterone or 10-7M estrogen Figure 4
Collagen Type I (μg) measured by ELISA in LAD fibroblasts 
treated with 10-7M testosterone or 10-7M estrogen. Testo-
sterone significantly increased the amount of collagen depos-
ited (2.912 ± 0.247 μg) compared to control values (2.475 ± 
0.211 μg) (* p < 0.05, 1 tailed t-test). Estrogen decreased the 
amount of collagen (2.103 ± 0.262 μg) compared to control 
(p = 0.058, 1 tailed t-test). Collagen was measured in wells 
with a 0.32 cm2 growth area from a 96 well culture plate.
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ing for α-SMA. This demonstrated that the cultures in this
study were predominantly fibroblasts and not cells that
had transformed into myofibroblasts.
Conclusion
In summary, we have demonstrated the following: 1) a
procedure for successful isolation and culture of rat LAD
fibroblasts; 2) an optimal timeline for rat fibroblast
migration and proliferation; 3) an experimental design for
hormone treatment of LAD fibroblast cell cultures; and 4)
testosterone increased collagen type I and estrogen
decreased collagen type I in LAD fibroblasts. We provide a
useful technique for isolating coronary artery adventitial
fibroblasts and have demonstrated the utility of this tech-
nique in experimentally determining their influence in
blood vessel physiology and pathology.
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